ATE116637T1 - Sulfonische stilbenderivate zur behandlung von viruserkrankungen. - Google Patents

Sulfonische stilbenderivate zur behandlung von viruserkrankungen.

Info

Publication number
ATE116637T1
ATE116637T1 AT91300914T AT91300914T ATE116637T1 AT E116637 T1 ATE116637 T1 AT E116637T1 AT 91300914 T AT91300914 T AT 91300914T AT 91300914 T AT91300914 T AT 91300914T AT E116637 T1 ATE116637 T1 AT E116637T1
Authority
AT
Austria
Prior art keywords
sulfonic
treatment
virus diseases
stilben derivatives
stilben
Prior art date
Application number
AT91300914T
Other languages
English (en)
Inventor
Alan D Cardin
Stanley A Tyms
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE116637T1 publication Critical patent/ATE116637T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/16—Isothiocyanates
    • C07C331/30—Isothiocyanates containing at least two isothiocyanate groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/16—Isothiocyanates
    • C07C331/28—Isothiocyanates having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91300914T 1991-02-05 1991-02-05 Sulfonische stilbenderivate zur behandlung von viruserkrankungen. ATE116637T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91300914A EP0498095B1 (de) 1991-02-05 1991-02-05 Sulfonische Stilbenderivate zur Behandlung von Viruserkrankungen

Publications (1)

Publication Number Publication Date
ATE116637T1 true ATE116637T1 (de) 1995-01-15

Family

ID=8208186

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91300914T ATE116637T1 (de) 1991-02-05 1991-02-05 Sulfonische stilbenderivate zur behandlung von viruserkrankungen.

Country Status (11)

Country Link
US (3) US5494932A (de)
EP (1) EP0498095B1 (de)
JP (1) JPH04338329A (de)
KR (1) KR0185683B1 (de)
AT (1) ATE116637T1 (de)
AU (1) AU652413B2 (de)
DE (1) DE69106493T2 (de)
DK (1) DK0498095T3 (de)
GR (1) GR3014998T3 (de)
IE (1) IE65161B1 (de)
ZA (1) ZA92669B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5670144A (en) * 1990-07-09 1997-09-23 Merrell Pharmaceuticals Inc. Anti-herpes virus and cytomegalovirus polyester oligomers
EP0498095B1 (de) * 1991-02-05 1995-01-04 Merrell Dow Pharmaceuticals Inc. Sulfonische Stilbenderivate zur Behandlung von Viruserkrankungen
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
EP0626945B1 (de) * 1992-02-20 1998-04-22 Merrell Pharmaceuticals Inc. Sulfonsaeurederivate zur behandlung von viruserkrankungen
IL112174A (en) * 1994-01-03 1999-05-09 Merrell Dow Pharma Oligomers of polythioureas pharmaceutical compositions containing them and a process for their preparation
CN1163401A (zh) * 1996-02-13 1997-10-29 李占元 全自动血球计数仪试剂及配制方法
DK0973735T3 (da) * 1997-04-10 2003-06-23 Upjohn Co Polyaromatiske antivirale præparater
US7105552B2 (en) * 1998-05-08 2006-09-12 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US6624197B1 (en) 1998-05-08 2003-09-23 Calyx Therapeutics, Inc. Diphenylethylene compounds
US6331633B1 (en) 1998-05-08 2001-12-18 Calyx Therapeutics Inc. Heterocyclic analogs of diphenylethylene compounds
US6245814B1 (en) 1998-05-08 2001-06-12 Calyx Therapeutics, Inc. Diphenylethylene compounds
US6310073B1 (en) * 1998-07-28 2001-10-30 Queen's University At Kingston Methods and compositions to treat glycosaminoglycan-associated molecular interactions
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US20020002200A1 (en) * 2000-02-04 2002-01-03 Bishwagit Nag Novel diphenylethylene compounds
US7323496B2 (en) * 1999-11-08 2008-01-29 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
US6525093B1 (en) * 1999-11-08 2003-02-25 Calyx Therapeutics Inc. Compounds to treat diabetes and associated conditions
US20080108825A1 (en) * 1999-11-08 2008-05-08 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
WO2001038530A1 (en) * 1999-11-24 2001-05-31 Takeda Chemical Industries, Ltd. Use of disease-associated gene
US20080103302A1 (en) * 2000-02-04 2008-05-01 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
EP1264177A2 (de) * 2000-02-10 2002-12-11 Panacos Pharmaceuticals, Inc. Verfahren zur detektion von viralen fusionsinhibitoren
DE102008001811A1 (de) * 2008-05-15 2009-11-19 Beiersdorf Ag Kosmetische Zubereitungen zur Verminderung von Schweißgeruch mit ABCC-Modulatoren
US10723834B1 (en) * 2018-04-13 2020-07-28 The United States Of America, As Represented By The Secretary Of The Navy Low melting and low viscosity thermoset matrix resins from the Z configuration of polyhydroxy stilbenes
WO2020104634A1 (en) * 2018-11-22 2020-05-28 Université de Nantes Disulfonate stilbenes for use in the treatment of proliferative diseases
CN116115757A (zh) * 2021-11-15 2023-05-16 中国农业科学院上海兽医研究所 疱疹病毒的细胞宿主因子ClC-2在制备抗疱疹病毒药物中的应用
EP4516298A1 (de) * 2023-09-01 2025-03-05 Thomas Szekeres Stilben-verbindungen zur verwendung bei der behandlung und prävention von infektionen mit dem cytomegalovirus (cmv)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE660945A (de) * 1964-03-12 1965-07-01
US4328244A (en) * 1980-05-21 1982-05-04 The Dow Chemical Company Novel (((substituted-phenyl)methyl)amino)benzenesulfonic acids and pharmaceutically-acceptable salts thereof
US4349568A (en) * 1980-06-12 1982-09-14 The Dow Chemical Company Sulfur-substituted diphenyl ethers having antiviral activity
US4435394A (en) * 1981-12-17 1984-03-06 Shionogi & Co., Ltd. 3-Sulfonamido-benzophenonimine derivatives useful for treating virus infections
DE3530718A1 (de) * 1985-08-28 1987-03-12 Madaus & Co Dr Methylendioxyphenanthren- und -stilbenderivate, verfahren zur herstellung derselben und arzneimittel, die diese enthalten
US4820452A (en) * 1985-10-16 1989-04-11 Ciba-Geigy Corporation Bechamp reduction of DNS to DAS using H2 SO4 and trace of HOAc
EP0221021B1 (de) * 1985-10-16 1989-11-08 Ciba-Geigy Ag Bechamp-Reduktion von DNS zu DAS mit H2SO4 und Spuren von HOAc
DE3626309A1 (de) * 1986-08-02 1988-02-18 Stockhausen Chem Fab Gmbh Antivirusmittel
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5124149A (en) * 1990-11-07 1992-06-23 The United States Of America As Represented By The Secretary Of Agriculture Compositions and methods for biocontrol using fluorescent brighteners
EP0498095B1 (de) * 1991-02-05 1995-01-04 Merrell Dow Pharmaceuticals Inc. Sulfonische Stilbenderivate zur Behandlung von Viruserkrankungen
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process

Also Published As

Publication number Publication date
JPH04338329A (ja) 1992-11-25
DE69106493T2 (de) 1995-06-29
AU652413B2 (en) 1994-08-25
IE65161B1 (en) 1995-10-04
EP0498095B1 (de) 1995-01-04
US5932614A (en) 1999-08-03
ZA92669B (en) 1992-11-25
EP0498095A1 (de) 1992-08-12
AU1062092A (en) 1992-08-13
IE920360A1 (en) 1992-08-12
US5672625A (en) 1997-09-30
GR3014998T3 (en) 1995-05-31
KR920016090A (ko) 1992-09-24
DE69106493D1 (de) 1995-02-16
KR0185683B1 (ko) 1999-05-01
US5494932A (en) 1996-02-27
DK0498095T3 (da) 1995-06-19

Similar Documents

Publication Publication Date Title
DE69106493D1 (de) Sulfonische Stilbenderivate zur Behandlung von Viruserkrankungen.
ATE165345T1 (de) Sulfonsaeurederivate zur behandlung von viruserkrankungen
ATE68697T1 (de) Verwendung von azolylmethyloxiranen zur bekaempfung von viralen erkrankungen.
DE3881299D1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
DK156098C (da) Thixotropt middel til brug ved fraktionering af blod
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
ATE142873T1 (de) Hemmung einer virusinfektion
ES2123048T3 (es) Analogos de nucleosidos antiviricos.
DE69030202D1 (de) Phenylalkan(en)-Säuren mit Leukotrien B4 antagonistischer Wirkung
DK178188A (da) Antivirusmiddel
ES2058203T3 (es) Derivados del acido pirocatequincarboxilico, su obtencion y empleo como substancias activas para medicamentos.
ATE88752T1 (de) Inaktivierung von human immunodeficiency virus (hiv) in proteinhaltigen loesungen durch phenole.
DK0576506T3 (da) Anvendelse af benzimidazol-anthelmintikum ved behandling af mikrosporidial-infektioner
DK384387D0 (da) Erythromycin-derivater til forebyggelse og behandling af sygdomme fremkaldt af virus
ATE135702T1 (de) Aryl- oder heteroaryl-1-alkyl-pyrrol-2- carbonsäure-derivate, zur behandlung von durch interleukin-1 hervorgerufenen erkrankungen
SE8206128D0 (sv) Farmaceutisk komposition for behandling av njurstenar framkallade genom infektion
ATE26267T1 (de) Pyrimidin-derivate, ausgestattet mit antiviraler wirkung.
ATE255417T1 (de) Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
ATE137968T1 (de) Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen
ATE189604T1 (de) Extrakte von piliostigma thonningii, deren verwendung und diese enthaltende zubereitungen
ES2108254T3 (es) Composicion del inhibidor de infeccion con virus del sida.
MX9400210A (es) Tratamiento de infecciones virales.
DK0470144T3 (da) D-Asparaginsyre-beta-hydroxamat til behandling af virale infektioner og tumorer
DE3372068D1 (en) Pharmaceutical compositions for treating resistant bacteria including anaerobes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee